Cell Therapy Program

Cell Therapy Program

Cell Therapy and Indications

Autologous Peripheral Blood Stem Cells 

  • Leukemia, lymphoma and other blood malignant tumors
  • Chronic ischemic stroke
  • Severe lower limb ischemia

Autologous Adipose Derived Stem Cells

  • Chronic or more than six weeks of unhealed wounds
  • Surface 20 % Above large area burns or skin trauma
  • Subcutaneous and soft tissue defects
  • Degenerative arthritis and cartilage defect of knee joint
  • Other superficial invasive techniques combined with adjuvant therapy

Autologous Bone Marrow Derived Stem Cells

  • Degenerative arthritis and cartilage defect of knee joint
  • Subcutaneous and soft tissue defects
  • Spinal cord injury

Autologous Immunocytes

  • Treatment of ineffective blood malignant tumors by standard treatment 
  • 13 phases of solid cancer treated by standard treatment
  • Solid Cancer Phase Fourth

Autologous Fibroblasts

  • Skin defects such as wrinkles, cavities, etc.
  • Body Surface Wound Repair
  • Other superficial minimally invasive techniques combined with adjuvant therapy

Autologous Cartilage Cells 

  • Articular cartilage defect